Skip to content ↓

In the Media

Media Outlet:
The Boston Globe
Publication Date:
Description:

MIT and a number of other local institutions have launched Landmark Bio, a cell and gene therapy manufacturing firm aimed at helping small startups develop experimental therapies that are reliable, consistent, and large enough to be used in clinical trials, reports Ryan Cross for The Boston Globe.

Related News